Archives
Industry None Too Impressed by FDA's New Program For Certain PMA Devices
The FDA announced a new program by which novel, high-risk devices can receive expedited review but the industry appears skeptical.  
(April, 2014)
5 Areas of MHealth Growth In The Future
A new report on the opportunities and increased investment in all parts of the mhealth ecosystem describes five segments that have the most potential for growth.  
(April, 2014)
3-D Printed Blood Recycling Machine Reduces Cost of Blood Transfusions
 Brightwak Ltd. says using 3-D printing components cut prototyping costs for its Hemosep a blood recycling machine by 96%.
(April, 2014)
FDA Stops Issuing NHRIC and NDC Codes for Devices
Use of the NHRIC and NDC system for medical devices is being phased out over a time period that corresponds with the compliance dates for UDI requirements. 
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#14)
Omar Ishrak, Chairman and CEO, Medtronic [Photo Courtesy of Medtronic] Last year, Ishrak made nearly $9 million, but his compensation fell 64.1% from 2012.      
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#13)
  Vincent A. Forlenza, Chairman, President and CEO, Becton Dickinson & Company   [Photo Adapted from Becton Dickinson YouTube Video] In 2013, Forlenza made $9.2 million, which was 2.5% less than what he made the previous year.     
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#12)
  Timothy M. Ring, Chairman and CEO, C.R. Bard     In 2013, made $9.4 million, a 6.8% increase from his compensation the previous year.    
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#11)
Kieran T. Gallahue, Chairman and CEO, CareFusion [Photo Courtesy of CareFusion] Gallague made $9.6 million in 2013, a drop of 3.4% from what he made the year before.    
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#10)
  Daniel J. Starks, President, Chairman, and CEO, St. Jude Medical [Photo Courtesy of St. Jude Medical] Last year, Starks made $9.7 million, which meant his annual compensation jumped 43.9% from 2012.     
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#9)
  Michael Mahoney, President and CEO, Boston Scientific [Photo Courtesy of Boston Scientific] In 2013, Mr. Michael F. Mahoney made $10.9 million. His compensation increased 0.6% from the previous year.   
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#8)
George Barrett, Chairman and CEO, Cardinal Health    [Photo Adapted from a Russell Reynolds Associates YouTube Video]  Barrett made $11. 5 million in 2013, a slight increase of 2.4% from the previous year's compensation.   
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#7)
David E.I. Pyott, Chairman and CEO, Allergan ,  Last year, Pyott made $12, million recording a big 43.2% drop from what he made in 2012.      
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#6)
Robert L. Parkinson, Chairman and CEO, Baxter International   In 2013, Parkinson made $16.2 million, a drop of 7.8% from his compensation the previous year.     
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#5)
  Inge G. Thulin, Chairman, President & CEO, 3M [Photo Adapted From A 3M YouTube Video] Last year Thulin made $16.4 million, up 10.7% from what his compensation was in 2012.    
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#4)
Alex Gorsky, Chairman and CEO, Johnson & Johnson     In 2013, Gorsky made $16.9 million, up a whopping 54.1% from what he made in 2012.     
(April, 2014)
Good Riddance to Kathleen Sebelius at HHS
Commentator Jim Dickinson says Sebelius, who resigned April 10, has the dubious distinctions of being the first HHS secretary to reverse a public commitment by a high-ranking FDA official and the only secretary to reverse an FDA scientific finding in the service of politics.
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#3)
  Lawrence H. Culp, Jr, President and CEO of Danaher [Photo obtained from Danaher Website] In 2013, Culp made $19.7 million, recording a10% drop in his annual compensation from the previous year.       
(April, 2014)
Poka-Yoke-Inspired Medical Device Packaging Can Help Prevent Errors
Medical device packaging designed with poka-yoke principles in mind can improve usability.
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#2)
  Jeffrey Immelt, Chairman and CEO, General Electric       Last year Immelt made $19.8 million, a decline of 23.4% from his 2012 compensation.      
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (slideshow)
2013 was a good year for public medtech companies. This chart shows why. So how did CEOs fare last year? When it comes to annual compensation, who comprises the medtech world's 1%? We researched MD+DI's Top 40 Medical Device Companies, including only U.S-based medtech co...
(April, 2014)
15 Highest-Paid MedTech CEOs In the U.S. (#1)
And the U.S. medtech CEO who made the most money in 2013 was ... Miles D, White, CEO of Abbot Labs      White made $20.9 million in 2013, a 17% drop from his compensation the previous year. Return to Beginning      
(April, 2014)
Q1 MedTech Financings Results Mixed While Total VC Investment Highest Since Q2, 2001
Venture capitalists invested the most money in the first quarter of this year since the second quarter of 2001, while medtech showed mixed results with less deals but more money invested compared with Q4 of last year.  
(April, 2014)
6 Products St. Jude Medical is Banking On in 2014
St. Jude Medical wants to deliver a higher growth rate in the U.S. Executives believe these six products will help achieve that.  
(April, 2014)
GUDID Submission Methods: Which One’s Right for You?
Medical device manufacturers can submit UDI data to FDA using one of four methods: FDA’s GUDID Web interface, custom software, a vendor-provided system, or an outsourced service.
(April, 2014)
Can Flash Glucose Monitoring Disrupt Diabetes Care (and Revive Abbott’s Diabetes Business)?
The technology doesn't require finger pricks and features sensors that last about twice as long as those used in traditional continuous glucose monitoring. Will it be the game-changer Abbott is hoping for? 
(April, 2014)